Compare StocksAXP vs HCA

American Express Company (AXP) vs HCA Healthcare, Inc. (HCA): Which Is the Better Buy in 2026?

As of 2026-09-17, AXP is undervalued at $312, with a DCF intrinsic value of $476 and a margin of safety of 34%. HCA is fairly valued at $430, with an intrinsic value of $474 and a margin of safety of 9%. Of the two, AXP has the wider margin of safety.

AXP
American Express Company
$312.43
VS
HCA
HCA Healthcare, Inc.
$430.43

Rewards

AXP
  • Gross margin of 62.3% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • American Express Company scores 100/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Return on equity has consistently exceeded 20% over 4 years, indicating efficient use of shareholder capital.
HCA
  • HCA Healthcare, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • HCA Healthcare, Inc. scores 95/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • Free cash flow has grown at a 23.1% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

AXP
  • Altman Z-Score of 0.93 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • Insiders have sold $3.0M worth of stock in the past 3 months — significant insider liquidation.
  • Free cash flow has declined at a 5.9% CAGR over the past 4 years — a concerning trend.
HCA

    Key Valuation Metrics

    Learn more →
    AXP
    HCA
    Valuation
    N/A
    Free Cash Flow
    $7.69B
    N/A
    FCF Yield
    8.25%
    18.97
    Trailing P/E
    14.43
    15.54
    Forward P/E
    13.44
    Quality & Moat
    12.19%
    ROIC
    18.12%
    34.38%
    ROE
    N/A
    62.34%
    Gross Margin
    42.58%
    1.27
    PEG Ratio
    1.30
    Balance Sheet Safety
    0.39
    Net Debt / Equity
    N/A
    N/A
    Interest Coverage
    N/A
    N/A
    Net Debt / EBITDA
    3.20
    1.22%
    Dividend Yield
    0.72%
    AXP: 2Ties: 2HCA: 3
    AXPHCA

    Historical Fundamentals

    Learn more →
    AXP

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    HCA

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    AXP
    $6.18
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $23.29B
    Δ Market Cap
    +$144.01B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    HCA
    $2.43
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $15.76B
    Δ Market Cap
    +$38.30B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    AXP
    34.4% Margin of Safety
    Price is 34.4% below estimated fair value
    Current Price: $312.43
    Fair Value: $476.32
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    HCA
    9.2% Margin of Safety
    Price is 9.2% below estimated fair value
    Current Price: $430.43
    Fair Value: $474.11
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    AXP

    Requires positive FCF to compute implied growth rate.

    HCA

    What growth rate is the market pricing in at $430?

    +8.5%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +6.8%

    The market implies +8.5% Owner Earnings growth, roughly in line with history — reasonably priced.

    Standard FCF implies +6.8%, reflecting ongoing growth investment.

    Economic Moat Score

    Learn more →
    AXP
    100/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat driven primarily by revenue predictability. Margin Stability is the area most vulnerable to competitive pressure.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    HCA
    95/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

    Forensic Accounting

    Learn more →
    AXP
    -2.51
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    HCA
    -2.78
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    AXP
    Insiders 22.6%Institutions 64.6%Retail & Other 12.8%
    No. of Institutional Holders3,783
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    HCA
    Insiders 16.6%Institutions 78.9%Retail & Other 4.5%
    No. of Institutional Holders1,871
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    AXP
    0
    Buys (3M)
    0
    Buys (12M)
    JOABAR RAYMOND D
    Officer
    $4,054
    @ $176.26 · 2025-04-09
    ANGELAKIS MICHAEL J
    Director
    $998,593
    @ $269.89 · 2025-03-07
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    HCA
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    AXP
    1
    Sells (3M)
    13
    Sells (12M)
    Total value (12M): $62.95M
    HERENA MONIQUE
    Officer
    $2.97M
    @ $337.41 · 2026-08-18
    MCNEAL GLENDA G
    Officer
    $2.39M
    @ $339.36 · 2026-06-15
    LIEBERMAN QUINN JESSICA
    Officer
    $909,661
    @ $300.02 · 2026-03-06
    JOABAR RAYMOND D
    Officer
    $4.77M
    @ $340.67 · 2026-02-19
    GROSFIELD HOWARD M
    Officer
    $2.82M
    @ $346.73 · 2026-02-12
    SEEGER LAUREEN E
    Officer
    $4.60M
    @ $360.99 · 2026-02-09
    RADHAKRISHNAN RAVIKUMAR S
    Chief Technology Officer
    $5.35M
    @ $356.58 · 2026-02-09
    PICKETT DENISE
    Officer
    $8.35M
    @ $356.91 · 2026-02-05
    MARRS ANNA
    Officer
    $9.60M
    @ $350.01 · 2026-02-05
    JOABAR RAYMOND D
    Officer
    $538,902
    @ $384.93 · 2025-12-12
    RUTLEDGE ELIZABETH
    Officer
    $18.01M
    @ $360.21 · 2025-10-31
    TABISH DOUGLAS J
    Officer
    $894,359
    @ $355.61 · 2025-10-23
    PICKETT DENISE
    Officer
    $1.75M
    @ $350.73 · 2025-10-22
    SQUERI STEPHEN J
    Chief Executive Officer
    $37.03M
    @ $329.86 · 2025-09-04
    HERENA MONIQUE
    Officer
    $2.83M
    @ $325.88 · 2025-09-03
    BUCKMINSTER DOUGLAS E
    Officer
    $7.67M
    @ $326.37 · 2025-09-02
    SEEGER LAUREEN E
    Officer
    $23.37M
    @ $296.90 · 2025-08-06
    MCNEAL GLENDA G
    Officer
    $15.47M
    @ $309.50 · 2025-07-29
    MARRS ANNA
    Officer
    $1.71M
    @ $310.77 · 2025-07-29
    MARQUEZ RAFAEL
    Officer
    $3.56M
    @ $296.93 · 2025-05-20
    GROSFIELD HOWARD M
    Officer
    $2.60M
    @ $275.50 · 2025-05-06
    MCNEAL GLENDA G
    Officer
    $799,009
    @ $264.66 · 2025-04-29
    MARRS ANNA
    President
    $6.32M
    @ $287.88 · 2025-03-04
    LIEBERMAN QUINN JESSICA
    Officer
    $897,590
    @ $296.43 · 2025-02-26
    MCNEAL GLENDA G
    Officer
    $2.29M
    @ $309.96 · 2025-02-11
    SQUERI STEPHEN J
    Chief Executive Officer
    $16.24M
    @ $319.45 · 2025-02-06
    JOABAR RAYMOND D
    Officer
    $3.53M
    @ $317.01 · 2025-02-05
    RADHAKRISHNAN RAVIKUMAR S
    Chief Technology Officer
    $3.03M
    @ $319.17 · 2025-02-05
    PICKETT DENISE
    Officer
    $7.25M
    @ $318.69 · 2025-02-05
    JOABAR RAYMOND D
    Officer
    $4.77M
    @ $313.94 · 2025-01-28
    LE CAILLEC CHRISTOPHE
    Chief Financial Officer
    $1.82M
    @ $303.48 · 2024-11-27
    SQUERI STEPHEN J
    Chief Executive Officer
    $48.90M
    @ $286.57 · 2024-11-07
    HERENA MONIQUE
    Officer
    $374,010
    @ $287.70 · 2024-11-07
    BUCKMINSTER DOUGLAS E
    Officer
    $3.55M
    @ $270.98 · 2024-10-29
    WILLIAMS ANRE D.
    Officer
    $21.05M
    @ $270.26 · 2024-10-22
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    HCA
    0
    Sells (3M)
    6
    Sells (12M)
    Total value (12M): $31.12M
    MCALEVEY MICHAEL R.
    Officer
    $903,537
    @ $533.37 · 2026-02-18
    BERRES JENNIFER
    Officer
    $4.13M
    @ $514.58 · 2026-02-11
    WYATT CHRISTOPHER F
    Officer
    $2.02M
    @ $505.00 · 2026-02-11
    CUFFE MICHAEL S
    Officer
    $747,135
    @ $498.09 · 2026-02-03
    HAZEN SAMUEL N
    Chief Executive Officer
    $21.48M
    @ $501.04 · 2026-02-03
    MCALEVEY MICHAEL R.
    Officer
    $1.84M
    @ $473.79 · 2025-11-05
    CUFFE MICHAEL S
    Officer
    $1.61M
    @ $418.84 · 2025-09-08
    FOSTER JON MARK
    Officer
    $5.80M
    @ $369.32 · 2025-05-13
    BERRES JENNIFER
    Officer
    $3.08M
    @ $322.59 · 2025-02-14
    AKDAMAR EROL R
    Officer
    $1.02M
    @ $353.00 · 2024-11-14
    BILLINGTON PHILLIP G
    Officer
    $1.36M
    @ $350.00 · 2024-11-14
    WHALEN KATHLEEN M
    Officer
    $527,677
    @ $357.99 · 2024-11-14
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    AXP
    FearGreed
    😐Neutral(41/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    HCA
    FearGreed
    😐Neutral(46/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    AXP
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (41)
    HCA
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (46)
    View AXP Full AnalysisView HCA Full Analysis

    Frequently Asked Questions: AXP vs HCA

    Is American Express Company or HCA Healthcare, Inc. more undervalued in 2026?

    Based on our discounted cash flow model, AXP trades at a 34.4% margin of safety (intrinsic value $476 vs. price $312), compared to HCA's 9.2% margin of safety (intrinsic $474 vs. $430).

    Which stock has a wider economic moat, American Express Company or HCA Healthcare, Inc.?

    AXP scores 100/100 (Wide moat), while HCA scores 95/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is American Express Company in financial distress?

    AXP's Altman Z-Score of 0.9 places it in the Distress zone, signaling elevated bankruptcy risk. HCA scores 2.7 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which stock has higher return on invested capital, American Express Company or HCA Healthcare, Inc.?

    HCA earns 18.1% ROIC versus AXP's 12.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, American Express Company's or HCA Healthcare, Inc.'s?

    HCA's dividend earns a safety score of 94/100 (Very Safe), compared to AXP's 94/100 (Very Safe). HCA has raised its dividend for 3 consecutive years.